• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

False elevation of serum CA 15-3 levels in patients under follow-up for breast cancer.

作者信息

Aguiar-Bujanda David, Bohn-Sarmiento Uriel, Aguiar-Morales Jose

出版信息

Breast J. 2004 Jul-Aug;10(4):375-6. doi: 10.1111/j.1075-122X.2004.21369.x.

DOI:10.1111/j.1075-122X.2004.21369.x
PMID:15239804
Abstract
摘要

相似文献

1
False elevation of serum CA 15-3 levels in patients under follow-up for breast cancer.
Breast J. 2004 Jul-Aug;10(4):375-6. doi: 10.1111/j.1075-122X.2004.21369.x.
2
Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results.
J BUON. 2007 Oct-Dec;12(4):487-92.
3
The serum tumor marker M3/M21 in the follow-up of breast cancer patients.血清肿瘤标志物M3/M21在乳腺癌患者随访中的应用
Anticancer Res. 1996 Sep-Oct;16(5B):3049-52.
4
Evaluation of CA 15-3 serum levels in breast cancer patients.
Minerva Chir. 1997 Mar;52(3):251-4.
5
Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.在非转移性乳腺癌患者的系列外周血样本中检测人乳腺珠蛋白mRNA并不能预测疾病复发。
Breast Cancer Res Treat. 2009 Mar;114(2):223-32. doi: 10.1007/s10549-008-0002-9. Epub 2008 Apr 13.
6
[Diagnostic value of BRCA1 and p16 gene methylation in sporadic breast cancer].
Ai Zheng. 2009 Apr;28(4):436-40.
7
Periodic measurement of serum carcinoembryonic antigen and carbohydrate antigen 15-3 levels as postoperative surveillance after breast cancer surgery.乳腺癌手术后定期检测血清癌胚抗原和糖类抗原15-3水平作为术后监测手段。
Surg Today. 2005;35(1):19-21. doi: 10.1007/s00595-004-2881-7.
8
Ca 15.3 in breast cancer: comparison of two assays and validation in a Mexican population.
Arch Med Res. 1997 Winter;28(4):523-6.
9
Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients.癌胚抗原（CEA）和糖类抗原15-3（CA 15-3）在转移性乳腺癌患者疾病进展过程中的重要性。
Anticancer Res. 2007 Jul-Aug;27(4A):1963-8.
10
[Routine use of serial plasmatic CA 15-3 determinations during the follow-up of patients treated for breast cancer. Evaluation as factor of early diagnosis of recurrence].[乳腺癌治疗患者随访期间连续血浆 CA 15-3 测定的常规应用。作为复发早期诊断因素的评估]
Ann Biol Clin (Paris). 2008 Jul-Aug;66(4):385-92. doi: 10.1684/abc.2008.0244.

引用本文的文献

1
Elevation of cancer antigen 15-3 owing to oncocytic renal neoplasm in a patient without evidence of breast cancer recurrence on follow-up: a case report.由于随访中无乳腺癌复发证据的嗜酸性肾肿瘤导致癌抗原 15-3 升高：病例报告。
J Med Case Rep. 2023 Dec 7;17(1):526. doi: 10.1186/s13256-023-04088-5.
2
Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study.甲状腺功能减退症与乳腺癌复发和全因死亡率的风险——一项丹麦基于人群的研究。
Breast Cancer Res. 2019 Mar 22;21(1):44. doi: 10.1186/s13058-019-1122-3.
3
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer.
乳腺癌的多学科筛查、诊断、治疗及随访。德国妇科和产科学会（DGGG）与德国癌症协会（DKG）指南（S3级别，德国医学科学协会注册编号032/045OL，2017年12月）——第1部分：乳腺癌筛查、诊断及治疗建议
Geburtshilfe Frauenheilkd. 2018 Oct;78(10):927-948. doi: 10.1055/a-0646-4522. Epub 2018 Oct 19.
4
Patients' view of routine follow-up after breast cancer treatment.患者对乳腺癌治疗后常规随访的看法。
Wien Klin Wochenschr. 2017 Nov;129(21-22):810-815. doi: 10.1007/s00508-017-1278-8. Epub 2017 Oct 17.
5
Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.乳腺癌诊断、治疗及随访的跨学科循证指南Ⅲ级：简版 - AWMF注册号：032 - 045OL AWMF登记号：032 - 045OL - 简版3.0，2012年7月
Geburtshilfe Frauenheilkd. 2013 Jun;73(6):556-583. doi: 10.1055/s-0032-1328689.